A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
Edgar T. Overton, Steven J. Lawrence, Jack T. Stapleton, Heinz Weidenthaler, Darja Schmidt, Brigitte Koenen, Günter Silbernagl, Katrin Nopora, Paul Chaplin
Topics & Concepts
MedicineAdverse effectImmunogenicityTolerabilitySeroconversionPopulationVaccinationBooster doseDosingInternal medicineImmunologyTiterAntibodyEnvironmental healthImmunotherapy and Immune ResponsesPoxvirus research and outbreaksSARS-CoV-2 and COVID-19 Research